医学
麻醉
科克伦图书馆
荟萃分析
随机对照试验
舒芬太尼
针灸科
药物治疗
芬太尼
可视模拟标度
外科
内科学
病理
替代医学
作者
Linxi Sun,Xuqiang Wei,Ke Wang,Zi Ye,Jia Zhou
出处
期刊:PubMed
[National Institutes of Health]
日期:2024-01-12
卷期号:44 (1): 109-122
被引量:3
标识
DOI:10.13703/j.0255-2930.20221008-0005
摘要
OBJECTIVES: To evaluate the clinical value and safety of combined anesthesia of acupuncture-pharmacotherapy in pulmonary resection surgery. METHODS: The randomized controlled trials (RCTs) related to combined anesthesia of acupuncture-pharmacotherapy in pulmonary resection surgery were searched in PubMed, EMbase, Cochrane Library, Web of Science, SinoMed, CNKI, VIP database, Wanfang database, ClinicalTrials.gov, and the Chinese Clinical Trial Registry (http://www.chictr.org.cn/) from the inception of each database up to July 12, 2022. The methodological quality of the included studies was assessed using the Cochrane risk of bias tool, and Meta-analysis was conducted using RevMan5.4. RESULTS: <0.000 01]. CONCLUSIONS: The combined anesthesia of acupuncture-pharmacotherapy in pulmonary resection surgery could improve anesthesia and analgesia effectiveness, reduce anesthesia drug usage, regulate immune responses, suppress stress reactions, and the safety is satisfactory. However, there is substantial heterogeneity among the included studies, and outcome measures vary widely. Further large-sample, high-quality, internationally standardized clinical trials are needed to clarify its clinical value and safety, providing reliable evidence for clinical practice.
科研通智能强力驱动
Strongly Powered by AbleSci AI